united states of addiction
Despite the growing epidemic of Americans misusing opioids and overdosing on the job, many employers turn a blind eye to addiction within their workforce—ill-equipped or unwilling to confront an issue they are at a loss to handle.
“Dopesick” looks at how the makers of OxyContin targeted doctors in struggling areas with terrifying precision—and tragic consequences.
One informant reported having been paid in heroin to live in a sober home and collect money from visitors who sexually assaulted female residents.
I posed as a potential customer and experienced the most aggressive marketing tactics.
“There’s nothing 'natural' about it. They’re just deadly chemicals made in a lab."
In 2001, opioids were a factor in 4.2 percent of deaths among people ages 25 to 34. By 2016, that number had nearly quadrupled to 20 percent.
The National Safety Council's "Prescribed to Death" memorial not only dehumanizes people, it also ignores those who died from street drugs like heroin. Trump will host it in front of the White House in April.
A new study suggests that geography is far less important in explaining overdose deaths than are family life and job opportunities.
Purdue Pharma, whose top-selling painkiller, OxyContin, helped fuel the opioid epidemic, now wants to help treat it—or at least salvage its own reputation.